Literature DB >> 187093

In vitro interferon production by bovine tissues: induction with infectious bovine rhinotracheitis virus.

R W Fulton, B D Rosenquist.   

Abstract

The interferon-inducing ability of infectious bovine rhinotracheitis (IBR) virus was determined in tissue cultures of bovine origin inoculated with untreated and ultraviolet (UV) irradiated IBR viruses. Interferon was assayed by the plaque-reduction method in bovine fetal kidney (BFK) cell cultures, using vesicular stomatitis virus as challenge virus. Highest interferon concentrations were produced by cultures of bovine fetal (BF) spleen cells and aveolar macrophage cultures derived from adult cattle. Moderate interferon concentrations were produced by peripheral blood leukocyte (PBL) suspension cultures from adult cattle with serum-neutralizing antibodies against IBR virus. Cultures of PBL from 1 cow without detectable serum-neutralizing antibodies against IBR virus did not produce detectable interferon in response to IBR virus. Cultures of PBL from cattle with or without detectable serum-neutralizing antibodies against IBR virus produced interferon when stimulated with phytohemagglutinin (PHA). Low levles of viral inhibitors were detected infrequently in monolayer cultures of BFK and BF nasal mucosa inoculated with UV-irradiated IBR virus and in BF tracheal organ cultures inoculated with untreated IBR virus. Interferon was not detected in fluids collected from IBR virus-exposed monolayer cultures of primary and secondary BF lung, secondary BF tracheal mucosa, secondary BF liver, secondary BF adrenal, and PBL in the 4th and 7th passages. The antiviral inhibitors from BF spleen, bovine alveolar macrophage, and PBL cultures induced with IBR virus, as well as inhibitors from PBL cultures induced with PHA, had the usual properties of interferon.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 187093

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  11 in total

1.  Antiviral activity in interferon-treated bovine tracheal organ cultures.

Authors:  R W Fulton; S K Root
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

2.  Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis.

Authors:  B Adler; H Adler; H Pfister; T W Jungi; E Peterhans
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

Review 3.  Effects of immunopotentiating agents on alveolar macrophage properties.

Authors:  B Charley
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1986       Impact factor: 2.268

4.  Interferon production by bovine tracheal organ cultures infected with bovid herpesvirus 1 strains.

Authors:  R W Fulton; N J Pearson
Journal:  Can J Comp Med       Date:  1980-10

5.  Properties of bovine interferons.

Authors:  V E Luna; A D Luk; S K Tyring; J M Hellman; S S Lefkowitz
Journal:  Experientia       Date:  1984-12-15

6.  Levels of interferon in blood serum and toxicity studies of bacteria-derived bovine alpha I1 interferon in dairy calves.

Authors:  J H Gillespie; F W Scott; C M Geissinger; C W Czarniecki; V T Scialli
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

7.  Interferon induction in bovine and feline monolayer cultures by four bluetongue virus serotypes.

Authors:  R W Fulton; N J Pearson
Journal:  Can J Comp Med       Date:  1982-01

8.  Susceptibility of feline herpesvirus 1 and a feline calicivirus to feline interferon and recombinant human leukocyte interferons.

Authors:  R W Fulton; L J Burge
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

9.  In vitro protective effect of bacteria-derived bovine alpha interferon I1 against selected bovine viruses.

Authors:  J H Gillespie; D S Robson; F W Scott; E I Schiff
Journal:  J Clin Microbiol       Date:  1985-12       Impact factor: 5.948

10.  Antiviral effects of bovine interferons on bovine respiratory tract viruses.

Authors:  R W Fulton; M M Downing; J M Cummins
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.